Editor’s Perspective

2023: An Extraordinary Year for Myopia Management

January 1, 2024

By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE

Juvenile-onset myopia has gained the scientific community’s attention, and 2023 was a stellar year for myopia publications. According to PubMed (using search terms myopia, myopia management, myopia control, juvenile-onset myopia, childhood myopia, progressive myopia), over 1,900 papers on various aspects of myopia have been published globally in the peer-reviewed literature during 2023.

Some of the most notable and clinically relevant peer-reviewed papers published in 2023 include:

  • Interventions for Myopia Control in Children: A Living Systematic Review and Network Meta‐Analysis
  • Juvenile-Onset Myopia — Who to Treat and How to Evaluate Success2
  • Clinical Outcomes of a Randomized Trial with Contact Lenses for Astigmatic Myopia Management3 
  • Establishing a Method to Estimate the Effect of Anti-Myopia Management Options on Lifetime Cost of Myopia4
  • Retrospective Review of the Effectiveness of Orthokeratology Versus Soft Peripheral Defocus Contact Lenses for Myopia Management in an Academic Setting5
  • Effect of Low-dose Atropine on Binocular Vision and Accommodation in Children Aged 6 to 17 Years6
  • Efficacy in Myopia Control: Does Race Matter?7                                      
  • Combined 0.01% Atropine with Orthokeratology in Childhood Myopia Control (AOK) Study: A 2-Year Randomized Clinical Trial8  
  • Benchmarking Large Language Models’ Performances for Myopia Care: A Comparative Analysis of ChatGPT-3.5, ChatGPT-4.0, and Google Bard9
  • Effect of Low-Concentration Atropine Eyedrops vs. Placebo on Myopia Incidence in Children10

The third series of International Myopia Institute white papers were published in 2023. This series highlights key areas of myopia research and management, including evidence around onset, progression, and management of myopia in the less typical young adult and pediatric (infant and pre-school children less than 5 years of age) populations, the role of the choroid in eye growth control and myopia management, and a detailed anatomic paper on the “non-pathological” ocular tissue changes observed in moderate to high myopia. Also included in this series is a report on the results of an international survey of practitioners on myopia management attitudes and strategies in clinical practice. Some of these papers include: 

Regularly reading the peer-reviewed literature is one way to ensure that you are providing the highest level of care and prescribing the most appropriate evidence-based treatments to children at risk of progressive myopia. To assist busy clinicians, Review of Myopia Management will continue to summarize the most clinically relevant peer-reviewed articles in its Research Reviews each month. 

We must strive to provide evidence-based treatments to our patients and promote awareness of myopia management. Let’s continue to be proactive in 2024!

Best professional regards,

Dwight H. Akerman, OD, MBA, FAAO, FBCLA, FIACLE
Chief Medical Editor



  1. Lawrenson, J. G., Shah, R., Huntjens, B., Downie, L. E., Virgili, G., Dhakal, R., … & Walline, J. J. (2023). Interventions for myopia control in children: a living systematic review and network meta‐analysis. Cochrane Database of Systematic Reviews, (2). DOI: https://doi.org/10.1002/14651858.CD014758.pub2
  2. Bullimore, M. A., & Brennan, N. A. (2023). Juvenile-onset myopia—who to treat and how to evaluate success. Eye, 1-5. DOI: https://doi.org/10.1038/s41433-023-02722-6
  3. Tomiyama, E. S., & Richdale, K. (2023). Clinical Outcomes of a Randomized Trial with Contact Lenses for Astigmatic Myopia Management. Optometry and Vision Science100(1), 9-16. DOI:https://doi.org/10.1097/OPX.0000000000001969
  4. Fricke, T. R., Sankaridurg, P., Naduvilath, T., Resnikoff, S., Tahhan, N., He, M., & Frick, K. D. (2023). Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia. British Journal of Ophthalmology107(8), 1043-1050. DOI: https://doi.org/10.1136/bjophthalmol-2021-320318
  5. Skidmore, K. V., Tomiyama, E. S., Rickert, M. E., Richdale, K., & Kollbaum, P. (2023). Retrospective review of the effectiveness of orthokeratology versus soft peripheral defocus contact lenses for myopia management in an academic setting. Ophthalmic and Physiological Optics43(3), 534-543. DOI: https://doi.org/10.1111/opo.13121
  6. Breliant, R., Pang, Y., Bandstra, A., & Kattouf, V. (2023). Effect of Low-dose Atropine on Binocular Vision and Accommodation in Children Ages 6 to 17 Years. Optometry and Vision Science: Official Publication of the American Academy of Optometry. DOI: https://doi.org/10.1097/OPX.0000000000002031
  7. Bullimore, M. A., & Brennan, N. A. (2023). Efficacy in Myopia control: Does race matter?. Optometry and Vision Science100(1), 5-8. DOI: https://doi.org/10.1097/OPX.0000000000001977
  8. Tan, Q., Ng, A. L., Cheng, G. P., Woo, V. C., & Cho, P. (2023). Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Contact Lens and Anterior Eye46(1), 101723. DOI: https://doi.org/10.1016/j.clae.2022.101723
  9. Lim, Z. W., Pushpanathan, K., Yew, S. M. E., Lai, Y., Sun, C. H., Lam, J. S. H., … & Tham, Y. C. (2023). Benchmarking large language models’ performances for myopia care: a comparative analysis of ChatGPT-3.5, ChatGPT-4.0, and Google Bard. EBioMedicine95. DOI:https://doi.org/10.1016/j.ebiom.2023.104770
  10. Yam, J. C., Zhang, X. J., Zhang, Y., Yip, B. H., Tang, F., Wong, E. S., … & Pang, C. P. (2023). Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial. JAMA329(6), 472-481.  DOI: https://doi.org/10.1001/jama.2022.24162
To Top